# Yliver as a Test to Early Diagnose HCC

> **NCT03767764** · — · COMPLETED · sponsor: **Corporacion Parc Tauli** · enrollment: 190 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Test Yliver

## Key facts

- **NCT ID:** NCT03767764
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-27
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03767764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03767764, "Yliver as a Test to Early Diagnose HCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03767764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*